Reacción #1857589

ord-07afc07c0aec4f2f827fd5473d6d55ab

Ecuación de reacción

O=C(O)Cn1nc(C(F)F)cc1C(F)F
[3,5-bis-(difluoromethyl)-1H-pyrazol-1-yl]acetic acid
O=C(Cl)C(=O)Cl
oxalyl chloride
O=C([O-])O.[Na+]
sodium hydrogencarbonate
O=Cc1cccc(F)c1C1CC(c2csc(C3CC[NH2+]CC3)n2)=NO1.[Cl-]
4-{4-[5-(2-fluoro-6-formylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidinium chloride
CCN(CC)CC
triethylamine
O=Cc1cccc(F)c1C1CC(c2csc(C3CCN(C(=O)Cn4nc(C(F)F)cc4C(F)F)CC3)n2)=NO1
2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-fluorobenzaldehyde

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroThe solvent and the excess reagent were removed under reduced pressure
  2. 2
    workup.DISSOLUTIONThe solid residue was again dissolved in dichloromethane (5 ml) and, at 0° C.
  3. 3
    workup.STIRRINGThe reaction mixture was stirred at room temperature overnight
  4. 4
    Otrothe aqueous phase was removed
  5. 5
    Extracciónextracted with ethyl acetate
  6. 6
    SecadoThe combined organic phases were dried over sodium sulphate
  7. 7
    Concentraciónconcentrated
  8. 8
    OtroPurification by column chromatography

Procedimiento

To a solution of [3,5-bis-(difluoromethyl)-1H-pyrazol-1-yl]acetic acid (58 mg) in dichloromethane (20 ml) were added, at 0° C., oxalyl chloride (94.5 mg) and one drop of N,N-dimethylformamide. The reaction mixture was stirred at room temperature for 2 hours. The solvent and the excess reagent were removed under reduced pressure. The solid residue was again dissolved in dichloromethane (5 ml) and, at 0° C., added dropwise to a solution of 4-{4-[5-(2-fluoro-6-formylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidinium chloride and triethylamine (5.0 eq.) in dichloromethane (15 ml). The reaction mixture was stirred at room temperature overnight. Then it was admixed with concentrated sodium hydrogencarbonate solution, and the aqueous phase was removed and extracted with ethyl acetate. The combined organic phases were dried over sodium sulphate and concentrated. Purification by column chromatography gave 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-fluorobenzaldehyde (55 mg).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09247748B2uspto-grants-2016_02